Vimarsana
Biggest News Aggregation in the World

Page 22 - Repligen Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Repligen Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Repligen Daily Today - Breaking & Trending Today

Repligen (NASDAQ:RGEN) Trading 4.3% Higher - Vimarsana News

Repligen (NASDAQ:RGEN) Trading 4.3% Higher

Repligen Co. (NASDAQ:RGEN – Get Rating) shares traded up 4.3% during mid-day trading on Wednesday . The stock traded as high as $178.26 and last traded at $177.66. 322,077 shares changed hands during mid-day trading, a decline of 41% from the average session volume of 547,335 shares. The stock had previously closed at $170.39. Analysts […]

Source: wkrb13.com
Contrasting Molecular Partners (NASDAQ:MOLN) and Repligen (NASDAQ:RGEN) - Vimarsana News

Contrasting Molecular Partners (NASDAQ:MOLN) and Repligen (NASDAQ:RGEN)

Repligen (NASDAQ:RGEN – Get Rating) and Molecular Partners (NASDAQ:MOLN – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation. Institutional and Insider Ownership 91.0% of Repligen shares are held by […]

Analysts Set Quilter plc (LON:QLT) Target Price at GBX 100.20 - Vimarsana News

Analysts Set Quilter plc (LON:QLT) Target Price at GBX 100.20

Shares of Repligen Co. (NASDAQ:RGEN – Get Rating) have received a consensus rating of “Moderate Buy” from the ten brokerages that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and six have assigned a buy recommendation to the […]

Analysts Set Repligen Co. (NASDAQ:RGEN) PT at $218.50 - Vimarsana News

Analysts Set Repligen Co. (NASDAQ:RGEN) PT at $218.50

Repligen Co. (NASDAQ:RGEN – Get Rating) has earned a consensus rating of “Moderate Buy” from the ten brokerages that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. The average […]

Source: wkrb13.com
Comerica Bank Purchases 12,309 Shares of Repligen Co. (NASDAQ:RGEN) - Vimarsana News

Comerica Bank Purchases 12,309 Shares of Repligen Co. (NASDAQ:RGEN)

Comerica Bank boosted its stake in Repligen Co. (NASDAQ:RGEN – Get Rating) by 11.7% in the fourth quarter, HoldingsChannel reports. The firm owned 117,682 shares of the biotechnology company’s stock after buying an additional 12,309 shares during the period. Comerica Bank’s holdings in Repligen were worth $21,850,000 as of its most recent SEC filing. A […]

Source: wkrb13.com